Search

Author/Creator Repsilber, D

1. DOP11 A novel diagnostic serum protein signature for paediatric Inflammatory Bowel Disease: A discovery and validation study in two independent inception cohorts. (30th January 2023)

Authors:
Bache-Wiig Mathisen, C; Nyström, N; Bazov, I; Andersen, S; Olbjørn, C; Perminow, G; Kristensen, V A; Opheim, R; Ricanek, P; D`Amato, M; Carlson, M; Hedin, C R; Keita, Å V; Kruse, R; Lindqvist, C M; Magnusson, M K; Salihovic, S; Söderholm, J D; Öhman, L; Repsilber, D
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. DOP14 Identification and validation of a lipidomic signature as a novel diagnostic biomarker of paediatric Inflammatory Bowel Disease. (30th January 2023)

Authors:
Salihovic, S; Nyström, N; Bache-Wiig Mathisen, C; Andersen, S; Olbjørn, C; Perminow, G; Opheim, R; Detlie, T E; Huppertz-Hauss, G; Bazov, I; Kruse, R; Lindqvist, C M; Hedin, C R H; Carlson, M; Öhman, L; Magnusson, M; Keita, Å V; Söderholm, J D; D'Amato, M; Orešič, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i76
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P154 A novel serum protein signature as biomarker for Inflammatory Bowel Disease: A diagnostic performance and prediction modelling study using data from two independent inception cohorts. (30th January 2023)

Authors:
Bazov, I; Kruse, R; Bergemalm, D; Eriksson, C; Hedin, C R; Carlson, M; van Nieuwenhoven, M; Keita, Å V; Magnusson, M K; Almer, S; Strid, H; Bache-Wiig Mathisen, C; Bengtsson, M B; Bergene Aabrekk, T; Medhus, A W; Detlie, T E; Frigstad, S O; Huppertz-Hauss, G; Opheim, R; Ricanek, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i314
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. PO.1.12 Transcriptome profiling and autoimmunity-related serological markers identify TP53 and C3aR as drug targets in neuropsychiatric systemic lupus erythematosus. (27th September 2022)

Authors:
Lindblom, J; Toro-Domínguez, D; Carnero-Montoro, E; Borghi, MO; Castillo, J; Iacobaeus, E; Enman, Y; Repsilber, D; Mohan, C; Alarcón-Riquelme, M; Barturen, G; Parodis, I
Journal:
Lupus science & medicine
Issue:
Volume 9(2022)Supplement 2
Page Start:
A29
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. PO.5.99 Drug repurposing for treating lupus nephritis based on transcriptome profiling and autoimmunity-related serological markers. (27th September 2022)

Authors:
Parodis, I; Lindblom, J; Toro-Domínguez, D; Carnero-Montoro, E; Borghi, MO; Castillo, J; Enman, Y; Repsilber, D; Mohan, C; Alarcón-Riquelme, M; Barturen, G
Journal:
Lupus science & medicine
Issue:
Volume 9(2022)Supplement 2
Page Start:
A78
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease. (17th November 2020)

Authors:
Kalla, R; Adams, A T; Bergemalm, D; Vatn, S; Kennedy, N A; Ricanek, P; Lindstrom, J; Ocklind, A; Hjelm, F; Ventham, N T; Ho, G T; Petren, C; Repsilber, D; Söderholm, J; Pierik, M; D'Amato, M; Gomollón, F; Olbjorn, C; Jahnsen, J; Vatn, M H
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15:Number 5(2021)
Page Start:
699
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗